Oculis Holding AG (OCS)
10.07
-0.53
(-5.00%)
USD |
NASDAQ |
Sep 15, 16:00
10.02
-0.05
(-0.50%)
After-Hours: 20:00
Oculis Price to Book Value : 2.286 for Sept. 15, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 14, 2026 | 2.406 |
| September 11, 2026 | 2.397 |
| September 10, 2026 | 2.568 |
| September 09, 2026 | 2.604 |
| September 08, 2026 | 2.761 |
| September 04, 2026 | 2.763 |
| September 03, 2026 | 2.763 |
| September 02, 2026 | 2.729 |
| September 01, 2026 | 2.765 |
| August 31, 2026 | 2.781 |
| August 28, 2026 | 2.772 |
| August 27, 2026 | 2.822 |
| August 26, 2026 | 2.945 |
| August 25, 2026 | 2.942 |
| August 24, 2026 | 2.992 |
| August 21, 2026 | 2.971 |
| August 20, 2026 | 2.983 |
| August 19, 2026 | 3.081 |
| August 18, 2026 | 2.994 |
| August 17, 2026 | 2.983 |
| August 14, 2026 | 2.938 |
| August 13, 2026 | 2.910 |
| August 12, 2026 | 2.926 |
| August 11, 2026 | 2.895 |
| August 10, 2026 | 2.897 |
| Date | Value |
|---|---|
| August 07, 2026 | 2.879 |
| August 06, 2026 | 2.811 |
| August 05, 2026 | 2.740 |
| August 04, 2026 | 2.722 |
| August 03, 2026 | 2.699 |
| July 31, 2026 | 2.568 |
| July 30, 2026 | 2.545 |
| July 29, 2026 | 2.461 |
| July 28, 2026 | 2.510 |
| July 27, 2026 | 2.502 |
| July 24, 2026 | 2.527 |
| July 23, 2026 | 2.597 |
| July 22, 2026 | 2.595 |
| July 21, 2026 | 2.715 |
| July 20, 2026 | 2.663 |
| July 17, 2026 | 2.768 |
| July 16, 2026 | 2.863 |
| July 15, 2026 | 2.979 |
| July 14, 2026 | 2.936 |
| July 13, 2026 | 2.985 |
| July 10, 2026 | 3.094 |
| July 09, 2026 | 3.110 |
| July 08, 2026 | 3.110 |
| July 07, 2026 | 3.078 |
| July 06, 2026 | 3.133 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Novartis AG | 6.109 |
| Roche Holding AG | -- |
| Addex Therapeutics Ltd. | 0.7931 |
| Sandoz Group AG | -- |
| Galderma Group AG | -- |
Price to Book Value Related Metrics
| Price | 10.07 |
| Earnings Yield | -17.46% |
| Market Cap | 621.64M |